Mostrar el registro sencillo del ítem

dc.contributor.authorLinertová, Renata
dc.contributor.authorValcárcel-Nazco, Cristina
dc.contributor.authorPosada De la Paz, Manuel 
dc.contributor.authorLópez-Bastida, Julio
dc.contributor.authorSerrano-Aguilar, Pedro
dc.contributor.authorBURQOL-RD Research Network
dc.date.accessioned2023-03-07T11:52:53Z
dc.date.available2023-03-07T11:52:53Z
dc.date.issued2016
dc.identifier.citationRare Dis Orphan Drugs. 2016, 3 (1): 5-10.es_ES
dc.identifier.issn2284-2543es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15579
dc.description.abstractMost of rare diseases lead to a certain level of disability. In Spain, disabled persons receive long-time benefits, but only if they possess a disability evaluation that officially certifies the degree of their disability. Sometimes, the affected persons can experience disagreement with the obtained evaluation. Our aim was to analyse the level of agreement among rare disease patients and caregivers in Spain with their official disability evaluation and its possible relationship with their health-related quality of life (HRQoL) and the general satisfaction with the national healthcare system (NHS). Data were collected from patients (n = 123) and caregivers (n = 74) as a part of BURQOL-RD Project that measured the burden of ten rare diseases in Europe. HRQoL was evaluated by the generic instrument EQ-5D. Satisfaction with NHS was measured on a scale from 1 to 10. Almost 30% of respondents did not agree with their disability evaluation. These persons expressed less satisfaction with NHS than those who were in accord with their evaluation (5.1 vs 6.8; p <0.0001). Patients’ and caregivers’ HRQoL was also worse for the disagreement group, but did not reach a statistical significance. Correctly evaluated degree of disability is fundamental and has many consequences for all affected parties. Disability evaluation rules should reflect the specificities of rare diseases.es_ES
dc.description.sponsorshipThis publication arises from the project “Social economic burden and health-related quality of life in patients with rare diseases in Europe (BURQOLRD)” which has received funding from the European Union in the framework of the Health Programme (Grant number A101205). The Executive Agency of the European Union is not responsible for any use that may be made of the information contained hereines_ES
dc.language.isoenges_ES
dc.publisherIstituto Superiore di Sanità (ISS) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectDisabilityes_ES
dc.subjectRare diseaseses_ES
dc.subjectBenefitses_ES
dc.subjectSatisfactiones_ES
dc.subjectHealth-related quality of lifees_ES
dc.titleDisability evaluation in patients with rare diseases in Spain: the importance of being in accord. BURQOL-RD Projectes_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.format.volume3es_ES
dc.format.number1es_ES
dc.format.page5-10es_ES
dc.contributor.funderUnión Europea es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2385-2364es_ES
dc.relation.publisherversionhttp://www.rarejournal.org/index.php/rarejournal/article/view/86es_ES
dc.identifier.journalRare Diseases and Orphan Drugs Journales_ES
dc.repisalud.centroISCIII::Instituto de Investigación de Enfermedades Rarases_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/A101205/EUes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 Internacional